Pomanda estimates the enterprise value of EPSOMEDICAL LIMITED at £9m based on a Turnover of £13.7m and 0.66x industry multiple (adjusted for size and gross margin).
epsomedical limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of EPSOMEDICAL LIMITED at £0 based on an EBITDA of £-613 and a 4.99x industry multiple (adjusted for size and gross margin).
epsomedical limitedEstimated Valuation
£1.1m
Pomanda estimates the enterprise value of EPSOMEDICAL LIMITED at £1.1m based on Net Assets of £443.7k and 2.5x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Epsomedical LimitedOverview
Epsomedical Limited is a live company located in cobham, KT11 1HS with a Companies House number of 03286288. It operates in the hospital activities sector, SIC Code 86101. Founded in December 1996, it's largest shareholder is
epsomedical (acquisitions) ltd
with a 100% stake. Epsomedical Limited is a mature,
mid sized company, Pomanda has estimated its turnover at
£13.7m with
low
growth in recent years.
Pomanda's financial health check has awarded Epsomedical Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
2 Strong
4 Regular
4 Weak
Size
annual sales of £13.7m, make it larger than the average company (£4.8m)
£13.7m - Epsomedical Limited
£4.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (8.1%)
0% - Epsomedical Limited
8.1% - Industry AVG
Production
with a gross margin of 34.3%, this company has a comparable cost of product (34.3%)
34.3% - Epsomedical Limited
34.3% - Industry AVG
Profitability
an operating margin of 0% make it less profitable than the average company (9.7%)
0% - Epsomedical Limited
9.7% - Industry AVG
Employees
with 182 employees, this is above the industry average (58)
182 - Epsomedical Limited
58 - Industry AVG
Pay Structure
on an average salary of £33.9k, the company has an equivalent pay structure (£33.9k)
£33.9k - Epsomedical Limited
£33.9k - Industry AVG
Efficiency
resulting in sales per employee of £75.5k, this is equally as efficient (£75.7k)
£75.5k - Epsomedical Limited
£75.7k - Industry AVG
Debtor Days
it gets paid by customers after 21 days, this is near the average (21 days)
21 days - Epsomedical Limited
21 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Epsomedical Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Epsomedical Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (40 weeks)
0 weeks - Epsomedical Limited
40 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 64.7%, this is a higher level of debt than the average (41.8%)
64.7% - Epsomedical Limited
41.8% - Industry AVG
EPSOMEDICAL LIMITED financials
EXPORT
Epsomedical Limited's latest turnover from March 2024 is estimated at £13.7 million and the company has net assets of £443.7 thousand. According to their latest financial statements, we estimate that Epsomedical Limited has 182 employees and maintains cash reserves of £13.7 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
13,746,644
6,934,690
408,042
13,656,629
3,076,623
10,757,764
2,853,710
1,205,227
6,268,695
32,181,070
8,297,362
7,647,394
9,222,208
8,375,842
Other Income Or Grants
Cost Of Sales
9,026,777
4,617,563
256,623
8,989,998
2,103,527
7,303,161
1,893,062
754,469
6,268,695
20,605,065
5,578,257
4,991,231
5,975,014
6,375,596
Gross Profit
4,719,868
2,317,127
151,419
4,666,631
973,096
3,454,602
960,647
450,758
11,576,005
2,719,105
2,656,163
3,247,194
2,000,245
Admin Expenses
4,720,481
2,321,506
154,833
4,667,399
969,192
3,455,824
964,664
452,103
40
47
14,920,219
1,683,713
1,514,743
3,249,171
1,867,028
Operating Profit
-613
-4,379
-3,414
-768
3,904
-1,222
-4,017
-1,345
-40
-47
-3,344,214
1,035,392
1,141,420
-1,977
133,217
Interest Payable
4
7
Interest Receivable
716
4,440
3,391
930
799
5,728
5,771
3,443
5,505
1,806
9,341
3,748
1,547
3,486
804
Pre-Tax Profit
103
60
-23
162
4,702
4,506
1,754
2,098
235,465
4,384,731
-3,334,873
1,039,136
1,142,960
1,508
134,021
Tax
-26
-11
-31
-893
-856
-333
-419
-1,093
-352
-262,354
-301,329
-422
-37,526
Profit After Tax
77
49
-23
131
3,809
3,650
1,421
1,678
234,372
4,384,379
-3,334,873
776,782
841,631
1,086
96,495
Dividends Paid
230,000
4,382,972
Retained Profit
77
49
-23
131
3,809
3,650
1,421
1,678
4,372
1,407
-3,334,873
776,782
841,631
1,086
96,495
Employee Costs
6,166,916
3,059,395
209,903
6,296,343
1,343,543
4,860,999
1,444,286
601,339
3,131,332
27,222
15,840,000
2,205,085
2,167,981
3,997,158
3,193,228
Number Of Employees
182
98
7
218
48
174
52
22
115
1
576
101
107
154
123
EBITDA*
-613
-4,379
-3,414
-768
3,904
-1,222
-4,017
-1,345
-40
-47
-3,344,214
1,035,392
1,141,420
-1,977
133,217
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
382,611
446,852
Intangible Assets
Investments & Other
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
Debtors (Due After 1 year)
Total Fixed Assets
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
250,000
382,611
446,852
250,000
250,000
Stock & work in progress
117,680
125,645
Trade Debtors
813,465
442,133
758,091
203,956
718,528
201,057
93,222
165,822
2,878,941
634,195
372,345
337,661
388,570
Group Debtors
180,000
228,670
310,171
230,969
230,969
230,969
252,882
Misc Debtors
843,830
805,402
109,337
255,567
329,671
Cash
13,678
13,593
195,340
708,864
1,150,546
446,694
1,080,807
1,227,666
1,526,662
1,401,551
3,736,577
3,084,892
1,072,835
321,494
misc current assets
total current assets
1,007,143
684,396
505,511
1,466,955
1,354,502
2,009,052
2,318,235
1,661,194
1,923,453
1,654,433
2,878,941
4,744,019
3,912,553
1,410,496
710,064
total assets
1,257,143
934,396
755,511
1,716,955
1,604,502
2,259,052
2,568,235
1,911,194
2,173,453
1,904,433
3,128,941
5,126,630
4,359,405
1,660,496
960,064
Bank overdraft
2
Bank loan
Trade Creditors
55,269
2,701,853
480,664
535,920
1,238,454
539,108
Group/Directors Accounts
813,466
490,803
256,709
1,271,562
1,050,070
1,818,580
2,131,936
1,476,230
936,875
1,475,584
262,354
301,329
other short term finances
hp & lease commitments
other current liabilities
18
11
1,837
111,007
856
333
419
803,711
352
621,651
536,977
total current liabilities
813,484
490,814
311,978
1,273,399
1,161,077
1,819,436
2,132,269
1,476,649
1,740,586
1,475,938
2,701,853
1,364,669
1,374,226
1,238,454
539,108
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
813,484
490,814
311,978
1,273,399
1,161,077
1,819,436
2,132,269
1,476,649
1,740,586
1,475,938
2,701,853
1,364,669
1,374,226
1,238,454
539,108
net assets
443,659
443,582
443,533
443,556
443,425
439,616
435,966
434,545
432,867
428,495
427,088
3,761,961
2,985,179
422,042
420,956
total shareholders funds
443,659
443,582
443,533
443,556
443,425
439,616
435,966
434,545
432,867
428,495
427,088
3,761,961
2,985,179
422,042
420,956
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
-613
-4,379
-3,414
-768
3,904
-1,222
-4,017
-1,345
-40
-47
-3,344,214
1,035,392
1,141,420
-1,977
133,217
Depreciation
Amortisation
Tax
-26
-11
-31
-893
-856
-333
-419
-1,093
-352
-262,354
-301,329
-422
-37,526
Stock
-117,680
-7,965
125,645
Debtors
322,662
360,632
-447,920
554,135
-1,358,402
324,930
803,900
36,737
143,909
-2,626,059
1,989,179
187,746
364,355
-50,909
388,570
Creditors
-55,269
55,269
-2,701,853
2,221,189
-55,256
-702,534
699,346
539,108
Accruals and Deferred Income
7
11
-1,837
-109,170
110,151
523
-86
-803,292
803,359
352
-621,651
84,674
536,977
Deferred Taxes & Provisions
Cash flow from operations
-323,294
-420,280
497,938
-664,104
1,471,564
-326,485
-808,336
-841,793
658,317
-75,841
-3,616,175
622,675
184,534
747,856
246,229
Investing Activities
capital expenditure
382,611
-91,585
-39,379
Change in Investments
250,000
-250,000
250,000
cash flow from investments
132,611
-91,585
210,621
-250,000
Financing Activities
Bank loans
Group/Directors Accounts
322,663
234,094
-1,014,853
221,492
-768,510
-313,356
655,706
539,355
-538,709
1,475,584
-262,354
-38,975
301,329
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1,721,506
324,461
interest
716
4,440
3,391
930
799
5,728
5,771
3,443
5,505
1,806
9,341
3,744
1,540
3,486
804
cash flow from financing
323,379
238,534
-1,011,462
222,422
-767,711
-307,628
661,477
542,798
-533,204
1,477,390
-253,013
-35,231
2,024,375
3,486
325,265
cash and cash equivalents
cash
85
-181,747
-513,524
-441,682
703,852
-634,113
-146,859
-298,996
125,111
1,401,551
-3,736,577
651,685
2,012,057
751,341
321,494
overdraft
-2
2
change in cash
85
-181,747
-513,524
-441,682
703,852
-634,113
-146,859
-298,996
125,113
1,401,549
-3,736,577
651,685
2,012,057
751,341
321,494
epsomedical limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for epsomedical limited. Get real-time insights into epsomedical limited's credit score, group structure and payment trends.
Perform a competitor analysis for epsomedical limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in KT11 area or any other competitors across 12 key performance metrics.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to epsomedical limited.
epsomedical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EPSOMEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
epsomedical limitedCompanies House Filings - See Documents
